HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Major CHC Players Backing European Trial of ‘Intelligent’ Pack Recycling

Executive Summary

Procter & Gamble, Johnson & Johnson and Nestlé are among a group of companies supporting a European trial of digital watermark technology designed to reduce product packaging waste.

You may also be interested in...



HBW Insight’s Key Takeaways From 2021: #2 Get Serious About Sustainability

In 2021 the consumer health industry ramped up its sustainability efforts, with many firms publishing ambitious “net zero” transition strategies. As 2022 gets underway, recyclable or reusable packaging and consumer behavior change stand out as priority areas for further work, alongside carbon emissions reduction. To counter potential accusations of “greenwashing,” companies must be truthful and transparent about their ESG progress.

UK Packaging Firm Claims First-To-Market 100% Recyclable Pill Packs

Has Klöckner Pentaplast cracked the sustainable pill pack problem with its new KpNext fully recyclable blister strip?

EU Business Round-Up: Vision Acquires Nutriment, P&G Researching Sustainable Supply Chains, ThermaCare Relaunched In Nordics

The latest European business news: Vision Healthcare grows subscription supplements offering with Nutriment acquisition; P&G opens sustainable supply chains innovation center in Germany; and Navamedic relaunches global pain-relief brand ThermaCare in the Nordics.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS151775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel